The crucial role of community pharmacists in balancing the impact of statins on kidney function in patients with diabetes mellitus: Recommendations for awareness, recognition, and management of diabetic nephropathy

Abstract

When considering statin medication for individuals with diabetes mellitus, conducting a comprehensive risk-benefit analysis becomes crucial. Community pharmacists are vital in mitigating the potential impact of statin drugs on renal function and optimizing pharmaceutical management for diabetic patients. They employ various strategies to carefully balance the effects of statins on renal function in individuals with diabetes. Pharmacists collaborate closely with other healthcare professionals, such as physicians and nephrologists, to establish a comprehensive understanding of the patient's medical history and kidney function. Pharmacists play a crucial role in evaluating renal function and identifying underlying kidney disease by acquiring and analyzing relevant laboratory data, including serum creatinine levels and estimated glomerular filtration rate (eGFR). In conclusion, the impact of diabetes and statin drugs on renal function remains a subject of ongoing discussion in the pharmaceutical field. Community pharmacists, through collaboration with healthcare specialists, meticulous monitoring and adjustment of medication regimens, patient education, and support for lifestyle changes, optimize therapy to minimize the potential impact on renal health while ensuring optimal lipid management.